We are live on ! Find out more
EAM

EFG Asset Management Portfolio holdings

AUM $773M
1-Year Est. Return 40.1%
This Fund
S&P 500
This Quarter Est. Return
+16.21%
1 Year Est. Return
+40.1%
3 Year Est. Return
+211.13%
5 Year Est. Return
10 Year Est. Return
AUM
$579M
AUM Growth
+$51.8M
Cap. Flow
-$7.99M
Cap. Flow %
-1.38%
Top 10 Hldgs %
19.57%
Holding
202
New
18
Increased
97
Reduced
75
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 34.24%
2 Technology 24.7%
3 Consumer Discretionary 13.25%
4 Industrials 10.52%
5 Communication Services 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCNO icon
176
nCino
NCNO
$2.02B
$1.18M 0.2%
31,443
+16,772
+114% +$528K
PLTR icon
177
Palantir
PLTR
$295B
$1.12M 0.19%
+48,705
New +$1.04M
GPCR icon
178
Structure Therapeutics
GPCR
$3.41B
$1.12M 0.19%
26,153
+8,763
+50% +$370K
SONO icon
179
Sonos
SONO
$1.73B
$1.04M 0.18%
54,754
+3,089
+6% +$54.8K
TXG icon
180
10x Genomics
TXG
$6B
$881K 0.15%
23,478
+1,325
+6% +$58.2K
DY icon
181
Dycom Industries
DY
$12B
$872K 0.15%
+6,076
New +$748K
AMGN icon
182
Amgen
AMGN
$208B
$861K 0.15%
+3,029
New +$886K
S icon
183
SentinelOne
S
$6.53B
$860K 0.15%
+36,913
New +$964K
ARWR icon
184
Arrowhead Research
ARWR
$11.9B
$793K 0.14%
+27,745
New +$888K
EXTR icon
185
Extreme Networks
EXTR
$3.94B
$710K 0.12%
61,573
+3,474
+6% +$47.4K
ZIP icon
186
ZipRecruiter
ZIP
$321M
$638K 0.11%
55,520
+3,133
+6% +$42.1K
CRSP icon
187
CRISPR Therapeutics
CRSP
$4.73B
$603K 0.1%
8,856
-65,422
-88% -$4.68M
VERA icon
188
Vera Therapeutics
VERA
$2.3B
$446K 0.08%
+10,343
New +$369K
SG icon
189
Sweetgreen
SG
$766M
$438K 0.08%
+17,361
New +$253K
SYRE icon
190
Spyre Therapeutics
SYRE
$8.54B
$423K 0.07%
+11,151
New +$323K
GSHD icon
191
Goosehead Insurance
GSHD
$2.2B
-17,838
Closed -$1.35M
GXO icon
192
GXO Logistics
GXO
$5.77B
-17,603
Closed -$1.08M
LNG icon
193
Cheniere Energy
LNG
$55.2B
-9,058
Closed -$1.55M
LPLA icon
194
LPL Financial
LPLA
$28.3B
-15,304
Closed -$3.48M
NKE icon
195
Nike
NKE
$61.9B
-14,932
Closed -$1.62M
PRGO icon
196
Perrigo
PRGO
$1.4B
-72,307
Closed -$2.33M
QDEL icon
197
QuidelOrtho
QDEL
$1.14B
-29,101
Closed -$2.15M
U icon
198
Unity
U
$13.8B
-81,615
Closed -$3.34M
WDAY icon
199
Workday
WDAY
$39.6B
-13,857
Closed -$3.83M
NARI
200
DELISTED
Inari Medical, Inc. Common Stock
NARI
-25,774
Closed -$1.67M

Similar funds

EFG Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, EFG Asset Management held 202 positions worth $579M, up 9.8% from $527M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

EFG Asset Management's Q1 2024 filing shows 18 new, 97 increased, 75 reduced and 12 closed positions. Its largest new stake was Carlisle Companies: 5,037 shares worth $1.97M. The largest sale was CRISPR Therapeutics, an estimated $4.68M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • EFG Asset Management's largest Q1 2024 buy was Carlisle Companies: 5,037 shares worth $1.97M.
  • EFG Asset Management added most to Alphabet (Google) Class A in Q1 2024, an estimated $3.42M increase.
  • EFG Asset Management's biggest Q1 2024 reduction was CRISPR Therapeutics, cutting an estimated $4.68M.
  • EFG Asset Management fully exited Workday in Q1 2024, selling an estimated $3.83M.
  • EFG Asset Management's ten largest holdings make up 20% of its $579M portfolio in Q1 2024.
  • EFG Asset Management opened 18 new positions and closed 12 in Q1 2024.
  • EFG Asset Management's portfolio value rose 9.8% quarter-over-quarter to $579M.

Based on EFG Asset Management's 13F filing for Q1 2024, filed 13 May 2024.